Long-Term SafEty and Clinical Outcomes of LivmArli in Patients in the United States (LEAP-US) | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Long-Term SafEty and Clinical Outcomes of LivmArli in Patients in the United States (LEAP-US)	Abnormalities, Multiple, Alagille syndrome, Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, bile duct disorder, biliary tract disorder, cardiovascular disorder, cholestasis, congenital heart disease, hereditary disease, intrahepatic cholestasis, liver disorder, progressive familial intrahepatic cholestasis type 1	Recruiting	Not stated	2026-10-08		NCT06193928

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Mirum Pharmaceuticals, Inc.	15

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Children Hospital of Pittsburgh	Pittsburgh	United States	1
Children's Healthcare of Atlanta - Emory University School of Medicine	Atlanta	United States	1
Children's Hospital Los Angeles CHLA	Los Angeles	United States	1
Children's Hospital of Philadelphia	Philadelphia	United States	434
Children's Mercy Kansas City, Department of Gastroenterology, Section of Hepatology	Kansas City	United States	1
Oregon Health and Science University, Division of Pediatric Gastroenterology, Department of Pediatrics	Portland	United States	1
Section of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics and the Digestive Health Institute, Children's Hospital of Colorado and University of Colorado	Aurora	United States	1
University of Utah, Division of Pediatric Gastroenterology, Hepatology and Nutrition	Salt Lake City	United States	1